Clinical spectrum of lymphoproliferative diseases
Clinical spectrum of lymphoproliferative diseases
复制标题
淋巴增殖性疾病的临床谱
作者:
D. Galton;D. Catovsky;E. Wiltshaw
Although highly diverse, the patterns of clinical presentation are consistent with the growing evidence that most lymphoproliferative diseases are monoclonal proliferations. The most malignant, usually poorly differentiated diffuse lymphocytic or “histiocytic” tumors may present as focal tumors localized to a primary, often extranodal, site. They metastasize like carcinomas by local invasion of adjacent tissues, spread to regional lymph nodes, and production of discrete distant blood‐borne deposits. Follicular lymphoma in its malignant phase may disseminate by this pathological process. The distribution of the well‐differentiated lymphocytic lymphomas, usually generalized at presentation, suggests a different mechanism of dissemination from a progenitor cell whose descendants may never form a tumor mass but appear to disseminate by the physiological process of recirculation appropriate to the type of lymphocyte involved. The lymphocytes concentrate preferentially in particular tissues or organs by a homing mechanism: thus follicular center B cells of the benign phase of follicular lymphoma home to lymph nodes where they give rise to multiple follicular structures, while the T‐cells of the Sézary‐mycosis fungoides complex have an affinity for skin. In the diffuse well‐differentiated lymphocytic lymphomas, the lymphocytes home to the lymph nodes, spleen and bone‐marrow. Malignant lymphoproliferative disease can also arise in a monoclone already generalized by physiological dissemination: examples are lymphoma arising in idiopathic cold‐haemagglutinin disease, and multifocal tumors in a‐chain disease (immunoproliferative small intestinal disease).
影响因子:
11.2
作者:
P. Carbone;H. Kaplan;K. Musshoff;D. Smithers;M. Tubiana
通讯作者:
P. Carbone;H. Kaplan;K. Musshoff;D. Smithers;M. Tubiana